Skip to main content
  • Bleeding Complications Remain ‘Frequent and Important’ in Patients Undergoing Transfemoral TAVR

    Despite important advancements over the past decade, bleeding remains frequent and potentially fatal in patients undergoing transfemoral transcatheter aortic valve replacement (TAVR), according to a new analysis of pooled patient-level trial data.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details